全文获取类型
收费全文 | 20669篇 |
免费 | 2616篇 |
国内免费 | 374篇 |
专业分类
耳鼻咽喉 | 126篇 |
儿科学 | 799篇 |
妇产科学 | 398篇 |
基础医学 | 1882篇 |
口腔科学 | 194篇 |
临床医学 | 2383篇 |
内科学 | 7189篇 |
皮肤病学 | 349篇 |
神经病学 | 1804篇 |
特种医学 | 344篇 |
外科学 | 2432篇 |
综合类 | 1313篇 |
现状与发展 | 1篇 |
一般理论 | 5篇 |
预防医学 | 1609篇 |
眼科学 | 715篇 |
药学 | 874篇 |
2篇 | |
中国医学 | 188篇 |
肿瘤学 | 1052篇 |
出版年
2024年 | 55篇 |
2023年 | 451篇 |
2022年 | 258篇 |
2021年 | 470篇 |
2020年 | 439篇 |
2019年 | 202篇 |
2018年 | 776篇 |
2017年 | 783篇 |
2016年 | 846篇 |
2015年 | 817篇 |
2014年 | 748篇 |
2013年 | 1019篇 |
2012年 | 1468篇 |
2011年 | 1494篇 |
2010年 | 958篇 |
2009年 | 923篇 |
2008年 | 1288篇 |
2007年 | 1233篇 |
2006年 | 1070篇 |
2005年 | 1186篇 |
2004年 | 1503篇 |
2003年 | 1309篇 |
2002年 | 1006篇 |
2001年 | 811篇 |
2000年 | 304篇 |
1999年 | 330篇 |
1998年 | 373篇 |
1997年 | 296篇 |
1996年 | 141篇 |
1995年 | 101篇 |
1994年 | 86篇 |
1993年 | 108篇 |
1992年 | 90篇 |
1991年 | 55篇 |
1990年 | 61篇 |
1989年 | 59篇 |
1988年 | 56篇 |
1987年 | 45篇 |
1986年 | 39篇 |
1985年 | 23篇 |
1984年 | 20篇 |
1983年 | 19篇 |
1982年 | 20篇 |
1981年 | 23篇 |
1980年 | 14篇 |
1977年 | 13篇 |
1975年 | 13篇 |
1974年 | 18篇 |
1968年 | 17篇 |
1928年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
M. Caselli A. Zullo G. Maconi F. Parente V. Alvisi T. Casetti D. Sorrentino G. Gasbarrini the Working Group of the Cervia II Meeting 《Digestive and liver disease》2007,39(8):782-789
Proper management of Helicobacter pylori infection in clinical practice--when supported by evidence-based data--is expected to produce substantial cost-efficacy advantages. This consideration has prompted the Cervia Working Group to organise a meeting of experts to update the National Guidelines on the diagnosis and treatment of H. pylori infection in Italy. Recommendations in the new European Guidelines were considered in the National setting, here in the light of factors such as the incidence of gastric cancer and gastric lymphoma, the accessibility to different diagnostic tools, the prevalence of bacterial resistance against antibiotics, and the availability of different drugs. The main revisions in respect to the previous guidelines include H. pylori eradication in non-ulcer dyspepsia patients and in non-steroidal, anti-inflammatory drug users, as well as in patients with idiopathic thrombocytopenic purpura and iron deficiency anaemia. The stool antigen test is now accepted as a valid test for confirmation of H. pylori eradication following therapy. New therapeutic approaches have been recommended for both first- (sequential therapy) and second-line (levofloxacin-based) treatment in our country. 相似文献
62.
Claus Neurohr Patrick Huppmann Hanno Leuchte Martin Schwaiblmair Iris Bittmann Gundula Jaeger Rudolf Hatz Lorenz Frey Peter Überfuhr Bruno Reichart Jürgen Behr for the Munich Lung Transplant Group 《American journal of transplantation》2005,5(12):2982-2991
Bronchiolitis obliterans syndrome (BOS) is the limiting factor to long-term survival after lung transplantation. Previous studies suggested respiratory viral tract infections are associated with the development of BOS. To identify the impact of virus detection in bronchoalveolar lavage (BAL) fluid, we analyzed BAL samples from 87 consecutive lung transplant recipients for human herpesvirus (HHV)-6, Epstein-Barr virus, Herpes simplex virus 1/2, Cytomegalovirus, respiratory syncytical virus and adenovirus by PCR. Acute rejection, BOS and death were recorded for a mean follow-up time of 3.27 +/- 0.47 years. Results of PCR analysis and other potential risk factors were entered into a Cox regression analysis of BOS predictors and death. Only acute rejection was a distinct risk factor for BOS of all stages, death and death from BOS. HHV-6 was detected in 20 patients. Univariate and multivariate analysis revealed that HHV-6 was associated with an increased risk to develop BOS > orb = stage 1 and death, separate from the risk attributable to acute rejection. Identification of HHV-6 DNA in BAL fluid is a potential risk factor for BOS. Our results warrant further studies to elucidate a possible causal link between HHV-6 and BOS. 相似文献
63.
Aims The Abciximab Before Direct Angioplasty and Stenting inMyocardial Infarction Regarding Acute and Long-term Follow-up(ADMIRAL) study demonstrated that early inhibition of the plateletglycoprotein IIb/IIIa (GP IIb/IIIa) receptor with abciximabled to improved coronary patency, left ventricular function,and clinical outcomes. The current long-term follow-up studyevaluated the durability of the positive outcomes. Methods and results The randomized double-blind ADMIRAL trialenrolled 300 patients who received either abciximab plus stentingor placebo plus stenting for the treatment of ST-elevation myocardialinfarction (STEMI). Abciximab (bolus of 0.25 mg/kg bodyweight, followed by 12 h infusion of 0.125 µg/kgper min) was administered to 149 patients, whereas 151 patientsreceived placebo. Long-term follow-up was conducted in a blindedmanner by either patient chart review or telephone interview.Long-term follow-up data were obtained on 288 patients (96%).After 3 years, using an intent-to-treat analysis, the outcomeof all-cause mortality occurred in 9.1% of abciximab-treatedpatients when compared with 12.2% of placebo patients, absoluteand relative risk reductions of 3.1 and 25%, respectively (P=0.36).Parallel KaplanMeier curves were observed for the cumulativeincidence of death or re-infarction, which was reduced from16.9% in the placebo group to 11.8% in the abciximab group,absolute and relative risk reductions of 5.1 and 30%, respectively(P=0.20). Rates of recurrent ischaemia were significantly reducedfrom 21.7 to 11.5% (P=0.05). Conclusion Adjunctive abciximab to primary stenting for STEMIelicits favourable clinical outcomes with the same absoluterisk reductions of hard clinical outcomes from 30 days up to3 years of follow-up. 相似文献
64.
65.
66.
67.
The quality of acute stroke units on a nation-wide level: the Austrian Stroke Registry for acute stroke units 总被引:1,自引:0,他引:1
M. M. Steiner M. Brainin for the participants in the Austrian Stroke Registry for Acute Stroke Units 《European journal of neurology》2003,10(4):353-360
Concepts for stroke units that cover the acute phase vary. Therefore, the network of acute stroke units that is being set up in Austria in a uniform way is of general interest. This nationwide network has been established in accordance to evidence-based recommendations and prespecified criteria for available resources. The location for such a unit follows a maximum of 90-min isochrones (transport time) to the hospital. The quality of the network is currently documented and the results are reported. A nationwide stroke registry was prospectively performed on 15 stroke units that were already functional in this network. The aim was to document the quality performance of Austrian stroke units, focusing on rapid admissions, ready availability of investigations and therapies performed. Outcome measures were Barthel scale, Rankin score and percentages of complications. Between August 1998 and December 2000, 2,313 patients with ischemic stroke or with primary intracerebral hemorrhage admitted to an Austrian stroke unit within 24 h after onset of symptoms were prospectively included. Forty-three percent of the patients had a moderate or severe stroke. Fifty-seven percent of all patients were admitted to the stroke unit within 3 h after the onset of symptoms. Twenty-seven percent of these patients were brought in by ambulance accompanied by an emergency physician. Two percent of patients were admitted by helicopter. Fifty-four percent of patients had their first brain imaging within 30 min after admission, another 26% within 3 h. Intravenous thrombolysis was performed in 4.1% of patients. The overall stroke-unit mortality was about 6.8% and mortality at 3 months was 12.9%. The outcome at 3 months showed a modified Rankin Scale score of 0 or 1 in 47% of patients, denoting none or mild impairment. This network of acute stroke units is highly efficient in terms of rapid admissions, short intrahospital delays, as well as rapid use of readily available investigations. Stroke units seem to be well accepted by the general public and the medical community because our data show that all types of strokes are treated in Austrian stroke units, including severe strokes. The total number of concurrently treated acute strokes in other institutions across Austria is not known and no formal comparison with other systems of hospitalized care was undertaken, therefore further research is necessary. 相似文献
68.
论公费医疗大额死亡病例的资源消耗与医学目的 总被引:4,自引:2,他引:2
从北京市公费医疗大额消耗的92例死亡病例的费用结构及住院城数的统计,提示由住院日地长,贵重卫生资源的盲目过量投入等而致。这与中国国情不符。因此,医学目的概念应更新,以及应如何正确对待死亡病例的医疗服务值得进行讨论。 相似文献
69.
谈医院改革趋势 总被引:4,自引:2,他引:2
梁若柽 《中华医院管理杂志》1997,13(1):23-25
由于我国经济体制的转轨,经济增长方式的转换,正在带动、辐射、影响并制约着医院的建设和发展,医院改革将朝着以下趋势深化:一是在区域卫生发展规划指导下建设医院;二是开展社区服务是医院服务保障模式改革的大趋势;三是医院体制改革将寻求实现政府计划与市场调节的最佳结合;四是社会医疗保险制度改革将对医院带来重大影响;五是深化和完善补偿机制与价值体系改革仍是医院的重要课题;六是加大法规建设力度形成依法治院的新格局。 相似文献
70.
通过对97例截瘫住院患者连续10年的Hb测定结果进行回顾性分组研究,结果表明,无并发症组10年中Hb分布较一致,其均值与正常人比较无显著性差异(P>0.05),但12.3%的病例Hb水平低于正常人下限;当截瘫并发泌尿系感染、尿毒症或难治性褥疮等病症时,则导致Hb水平的降低。提出Hb测定结果,可做为在整体水平上观察截瘫患者的治疗及康复效果的指标。 相似文献